{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:34:50Z","timestamp":1792460090220,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11095-018-2457-7","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T15:14:22Z","timestamp":1531754062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study"],"prefix":"10.1007","volume":"35","author":[{"given":"Farhan","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Kumar","family":"Kondapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"2457_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"2457_CR2","unstructured":"I.A.f.R.o. Cancerand W.H. Organization. GLOBOCAN: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012, IARC2014."},{"key":"2457_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.biomaterials.2015.02.002","volume":"51","author":"M Li","year":"2015","unstructured":"Li M, Tang Z, Zhang D, Sun H, Liu H, Zhang Y, et al. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models. Biomaterials. 2015;51:161\u201372.","journal-title":"Biomaterials"},{"key":"2457_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"e2105","author":"J Terzic","year":"2010","unstructured":"Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 138. 2010;e2105:2101\u201314.","journal-title":"Gastroenterology 138"},{"key":"2457_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.biotechadv.2012.08.005","volume":"31","author":"IS Santos","year":"2013","unstructured":"Santos IS, Ponte BM, Boonme P, Silva AM, Souto EB. Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer. Biotechnol Adv. 2013;31:514\u201323.","journal-title":"Biotechnol Adv"},{"key":"2457_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29:1465\u201371.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"2457_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3816\/CCC.2002.n.016","volume":"2","author":"E Calvo","year":"2002","unstructured":"Calvo E, Cortes J, Rodriguez J, Fernandez-Hidalgo O, Rebollo J, Martin-Algarra S, et al. Irinotecan, oxaliplatin, and 5-fluorouracil\/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. Clin Colorectal Cancer. 2002;2:104\u201310.","journal-title":"Clin Colorectal Cancer"},{"key":"2457_CR8","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ejca.2005.04.026","volume":"41","author":"SM Guichard","year":"2005","unstructured":"Guichard SM, Macpherson JS, Thurston DE, Jodrell DI. Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136. Eur J Cancer. 2005;41:1811\u20138.","journal-title":"Eur J Cancer"},{"key":"2457_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1248\/bpb.b13-00540","volume":"37","author":"AS Lila","year":"2014","unstructured":"Lila AS, Kiwada H, Ishida T. Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin. Biol Pharm Bull. 2014;37:206\u201311.","journal-title":"Biol Pharm Bull"},{"key":"2457_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0925-4439(02)00082-0","volume":"1587","author":"GJ Peters","year":"2002","unstructured":"Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta. 2002;1587:194\u2013205.","journal-title":"Biochim Biophys Acta"},{"key":"2457_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-9966-31-23","volume":"31","author":"M Song","year":"2012","unstructured":"Song M, Zang W, Zhang B, Cao J, Yang G. GCS overexpression is associated with multidrug resistance of human HCT-8 colon cancer cells. Journal of experimental & clinical cancer research : CR. 2012;31:23.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"2457_CR12","first-page":"1","volume":"8","author":"S KUMARI","year":"2016","unstructured":"KUMARI S, KONDAPI AK. Cancer nanotechnology: current status and glimpse into the future. International Journal of Pharmaceutical Research. 2016;8:1.","journal-title":"International Journal of Pharmaceutical Research"},{"key":"2457_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","volume":"63","author":"AZ Wang","year":"2012","unstructured":"Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185\u201398.","journal-title":"Annu Rev Med"},{"key":"2457_CR14","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1038\/s41598-017-06888-4","volume":"7","author":"S Kumari","year":"2017","unstructured":"Kumari S, Ahsan SM, Kumar JM, Kondapi AK, Rao NM. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). Sci Rep. 2017;7:6602.","journal-title":"Sci Rep"},{"key":"2457_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2174\/18715206113139990325","volume":"13","author":"J Prados","year":"2013","unstructured":"Prados J, Melguizo C, Ortiz R, Perazzoli G, Cabeza L, Alvarez PJ, et al. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs. Anti Cancer Agents Med Chem. 2013;13:1204\u201316.","journal-title":"Anti Cancer Agents Med Chem"},{"key":"2457_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1208\/s12248-015-9761-5","volume":"17","author":"R Ortiz","year":"2015","unstructured":"Ortiz R, Cabeza L, Arias JL, Melguizo C, Alvarez PJ, Velez C, et al. Poly(butylcyanoacrylate) and poly(epsilon-caprolactone) nanoparticles loaded with 5-fluorouracil increase the cytotoxic effect of the drug in experimental Colon Cancer. AAPS J. 2015;17:918\u201329.","journal-title":"AAPS J"},{"key":"2457_CR17","first-page":"42","volume":"2012","author":"R Aydinand","year":"2012","unstructured":"Aydinand R, Pulat M. 5-fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:42.","journal-title":"J Nanomater"},{"key":"2457_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jbm.a.31084","volume":"81","author":"SJ Chang","year":"2007","unstructured":"Chang SJ, Niu GC, Kuo SM, Chen SF. Preparation and preliminary characterization of concentric multi-walled chitosan microspheres. J Biomed Mater Res A. 2007;81:554\u201366.","journal-title":"J Biomed Mater Res A"},{"key":"2457_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nano.2009.03.002","volume":"6","author":"A Jain","year":"2010","unstructured":"Jain A, Jain SK, Ganesh N, Barve J, Beg AM. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine : nanotechnology, biology, and medicine. 2010;6:179\u201390.","journal-title":"Nanomedicine : nanotechnology, biology, and medicine"},{"key":"2457_CR20","first-page":"1499","volume":"8","author":"W Sun","year":"2013","unstructured":"Sun W, Chen Y, Yuan W. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors. Int J Nanomedicine. 2013;8:1499\u2013506.","journal-title":"Int J Nanomedicine"},{"key":"2457_CR21","first-page":"5769","volume":"7","author":"N Ashwanikumar","year":"2012","unstructured":"Ashwanikumar N, Kumar NA, Nair SA, Kumar G. Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomedicine. 2012;7:5769\u201379.","journal-title":"Int J Nanomedicine"},{"key":"2457_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejpb.2007.11.002","volume":"69","author":"JL Arias","year":"2008","unstructured":"Arias JL, Gallardo V, Ruiz MA, Delgado \u00c1V. Magnetite\/poly (alkylcyanoacrylate)(core\/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur J Pharm Biopharm. 2008;69:54\u201363.","journal-title":"Eur J Pharm Biopharm"},{"key":"2457_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1021\/mp200023y","volume":"8","author":"M Kuruppuarachchi","year":"2011","unstructured":"Kuruppuarachchi M, Savoie H, Lowry A, Alonso C, Boyle RW. Polyacrylamide nanoparticles as a delivery system in photodynamic therapy. Mol Pharm. 2011;8:920\u201331.","journal-title":"Mol Pharm"},{"key":"2457_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2407-10-402","volume":"10","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gong C, Yang L, Wu Q, Shi S, Shi H, et al. 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. BMC Cancer. 2010;10:402.","journal-title":"BMC Cancer"},{"key":"2457_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/10717544.2013.875603","volume":"22","author":"Y Wang","year":"2015","unstructured":"Wang Y, Li P, Chen L, Gao W, Zeng F, Kong LX. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Drug delivery. 2015;22:191\u20138.","journal-title":"Drug delivery"},{"key":"2457_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051960","volume":"7","author":"K Golla","year":"2012","unstructured":"Golla K, Cherukuvada B, Ahmed F, Kondapi AK. Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS One. 2012;7:e51960.","journal-title":"PLoS One"},{"key":"2457_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007240","volume":"4","author":"AD Krishna","year":"2009","unstructured":"Krishna AD, Mandraju RK, Kishore G, Kondapi AK. An efficient targeted drug delivery through apotransferrin loaded nanoparticles. PLoS One. 2009;4:e7240.","journal-title":"PLoS One"},{"key":"2457_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijbiomac.2014.07.041","volume":"70","author":"F Ahmed","year":"2014","unstructured":"Ahmed F, Ali MJ, Kondapi AK. Carboplatin loaded protein nanoparticles exhibit improve anti-proliferative activity in retinoblastoma cells. Int J Biol Macromol. 2014;70:572\u201382.","journal-title":"Int J Biol Macromol"},{"key":"2457_CR29","doi-asserted-by":"crossref","unstructured":"Kumari S, Kondapi AK. Receptor-mediated targeted delivery of DNA using Lactoferrin nanoparticles. Int J Biol Macromol. 2017;","DOI":"10.1016\/j.ijbiomac.2017.11.160"},{"key":"2457_CR30","doi-asserted-by":"publisher","first-page":"644","DOI":"10.7150\/jca.7093","volume":"4","author":"K Golla","year":"2013","unstructured":"Golla K, Bhaskar C, Ahmed F, Kondapi AK. A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer. J Cancer. 2013;4:644\u201352.","journal-title":"J Cancer"},{"key":"2457_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuint.2016.01.006","volume":"95","author":"VS Bollimpelli","year":"2016","unstructured":"Bollimpelli VS, Kumar P, Kumari S, Kondapi AK. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity. Neurochem Int. 2016;95:37\u201345.","journal-title":"Neurochem Int"},{"key":"2457_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1267\/ahc.38.323","volume":"38","author":"FS Al-Joudi","year":"2005","unstructured":"Al-Joudi FS, Alias IZ, Samsudin A-R. The effects of chemotherapeutic drugs on viabilty, apoptosis, and survivin expression in MCF-7 cells. Acta Histochem Cytochem. 2005;38:323\u201330.","journal-title":"Acta Histochem Cytochem"},{"key":"2457_CR33","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1349-7006.2009.01287.x","volume":"100","author":"K Yoshimi","year":"2009","unstructured":"Yoshimi K, Tanaka T, Takizawa A, Kato M, Hirabayashi M, Mashimo T, et al. Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci. 2009;100:2022\u20137.","journal-title":"Cancer Sci"},{"key":"2457_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"JA Meyerhardtand","year":"2005","unstructured":"Meyerhardtand JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476\u201387.","journal-title":"N Engl J Med"},{"key":"2457_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijbiomac.2016.10.110","volume":"95","author":"S Kumari","year":"2017","unstructured":"Kumari S, Kondapi AK. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy. Int J Biol Macromol. 2017;95:232\u20137.","journal-title":"Int J Biol Macromol"},{"key":"2457_CR36","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1167\/iovs.09-3914","volume":"50","author":"D Shome","year":"2009","unstructured":"Shome D, Poddar N, Sharma V, Sheorey U, Maru GB, Ingle A, et al. Does a nanomolecule of carboplatin injected periocularly help in attaining higher intravitreal concentrations? Invest Ophthalmol Vis Sci. 2009;50:5896\u2013900.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2457_CR37","first-page":"62","volume":"23","author":"S Chaleawlert-umponand","year":"2009","unstructured":"Chaleawlert-umponand S, Pimpha N. Morphology study of superparamagnetic iron oxide-chitosan nanoparticles. Journal of Microscopy Society of Thailand. 2009;23:62\u20135.","journal-title":"Journal of Microscopy Society of Thailand"},{"key":"2457_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00396-003-0975-1","volume":"282","author":"O Regev","year":"2004","unstructured":"Regev O, Gohy J-F, Lohmeijer BG, Varshney SK, Hubert DH, Frederik PM, et al. Dynamic light scattering and cryogenic transmission electron microscopy investigations on metallo-supramolecular aqueous micelles: evidence of secondary aggregation. Colloid Polym Sci. 2004;282:407\u201311.","journal-title":"Colloid Polym Sci"},{"key":"2457_CR39","doi-asserted-by":"crossref","unstructured":"Salmasoand S, Caliceti P. Stealth properties to improve therapeutic efficacy of drug nanocarriers. Journal of drug delivery. 2013;2013","DOI":"10.1155\/2013\/374252"},{"key":"2457_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1166\/jbn.2011.1320","volume":"7","author":"N Sanoj Rejinold","year":"2011","unstructured":"Sanoj Rejinold N, Muthunarayanan M, Chennazhi K, Nair S, Jayakumar R. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J Biomed Nanotechnol. 2011;7:521\u201334.","journal-title":"J Biomed Nanotechnol"},{"key":"2457_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijbiomac.2010.10.003","volume":"48","author":"NS Rejinold","year":"2011","unstructured":"Rejinold NS, Muthunarayanan M, Chennazhi K, Nair S, Jayakumar R. 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int J Biol Macromol. 2011;48:98\u2013105.","journal-title":"Int J Biol Macromol"},{"key":"2457_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1166\/jnn.2009.J065","volume":"9","author":"H Yang","year":"2009","unstructured":"Yang H, Li K, Liu Y, Liu Z, Miyoshi H. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. J Nanosci Nanotechnol. 2009;9:282\u20137.","journal-title":"J Nanosci Nanotechnol"},{"key":"2457_CR43","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/jcbfm.2009.104","volume":"29","author":"R Huang","year":"2009","unstructured":"Huang R, Ke W, Han L, Liu Y, Shao K, Ye L, et al. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2009;29:1914\u201323.","journal-title":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"2457_CR44","doi-asserted-by":"crossref","unstructured":"Kanwar JR, Samarasinghe RM, Sehgal R, Kanwar RK. Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases. Journal of Cancer Science & Therapy. 2012;2012","DOI":"10.4172\/1948-5956.1000107"},{"key":"2457_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2008.10.016","volume":"134","author":"K Hu","year":"2009","unstructured":"Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. Journal of controlled release : official journal of the Controlled Release Society. 2009;134:55\u201361.","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"key":"2457_CR46","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/ijms14022862","volume":"14","author":"F-YJ Huang","year":"2013","unstructured":"Huang F-YJ, Chen W-J, Lee W-Y, Lo S-T, Lee T-W, Lo J-M. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. Int J Mol Sci. 2013;14:2862\u201374.","journal-title":"Int J Mol Sci"},{"key":"2457_CR47","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/jcp.22650","volume":"226","author":"R Jiang","year":"2011","unstructured":"Jiang R, Lopez V, Kelleher SL, L\u00f6nnerdal B. Apo-and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in caco-2 cells. J Cell Physiol. 2011;226:3022\u201331.","journal-title":"J Cell Physiol"},{"key":"2457_CR48","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11095-010-0189-4","volume":"27","author":"K Hanada","year":"2010","unstructured":"Hanada K, Suda M, Kanai N, Ogata H. Pharmacokinetics and toxicodynamics of oxaliplatin in rats: application of a toxicity factor to explain differences in the nephrotoxicity and myelosuppression induced by oxaliplatin and the other platinum antitumor derivatives. Pharm Res. 2010;27:1893\u20139.","journal-title":"Pharm Res"},{"key":"2457_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1523-1755.2004.00720.x","volume":"66","author":"T Ludwig","year":"2004","unstructured":"Ludwig T, Riethm\u00fcller C, Gekle M, Schwerdt G, Oberleithner H. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int. 2004;66:196\u2013202.","journal-title":"Kidney Int"},{"key":"2457_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4419-6306-2_20","volume":"678","author":"PM Wigmore","year":"2010","unstructured":"Wigmore PM, Mustafa S, El-Beltagy M, Lyons L, Umka J, Bennett G. Effects of 5-FU. Adv Exp Med Biol. 2010;678:157\u201364.","journal-title":"Adv Exp Med Biol"},{"key":"2457_CR51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ctrv.2008.04.003","volume":"34","author":"LS Jabr-Milane","year":"2008","unstructured":"Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008;34:592\u2013602.","journal-title":"Cancer Treat Rev"},{"key":"2457_CR52","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1039\/c2cs15344k","volume":"41","author":"N Kamaly","year":"2012","unstructured":"Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41:2971\u20133010.","journal-title":"Chem Soc Rev"},{"key":"2457_CR53","unstructured":"A.K. Udofot O, Krishnan S, Israel B, Agyare E. Pharmacokinetic and Efficacy Study of pH-Sensitive Liposomal Nanoparticles-Loaded 5-FU in Mice, AAPS annual meeting and exposition Vol. M11092015."},{"key":"2457_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1745-7254.2005.00530.x","volume":"26","author":"Y Jin","year":"2005","unstructured":"Jin Y, Li J, HUANG Y. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice1. Acta Pharmacol Sin. 2005;26:250\u20136.","journal-title":"Acta Pharmacol Sin"},{"key":"2457_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2407-8-103","volume":"8","author":"S Li","year":"2008","unstructured":"Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer. 2008;8:103.","journal-title":"BMC Cancer"},{"key":"2457_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/21691401.2014.883402","volume":"43","author":"H Wei","year":"2015","unstructured":"Wei H, Xu L, Sun Y, Li G, Cui Z, Yan G, et al. Preliminary pharmacokinetics of PEGylated oxaliplatin polylactic acid nanoparticles in rabbits and tumor-bearing mice. Artificial cells, nanomedicine, and biotechnology. 2015;43:258\u201362.","journal-title":"Artificial cells, nanomedicine, and biotechnology"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2457-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2457-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2457-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T23:19:04Z","timestamp":1563232744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2457-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2457"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2457-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"22 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"178"}}